Literature DB >> 10446255

E2F/p107 and E2F/p130 complexes are regulated by C/EBPalpha in 3T3-L1 adipocytes.

N A Timchenko1, M Wilde, P Iakova, J H Albrecht, G J Darlington.   

Abstract

We have previously found that loss of C/EBPalpha in hepatocytes of newborn livers leads to increased proliferation, to a reduction in p21 protein levels and to an induction of S phase-specific E2F/p107 complexes. In this paper, we investigated C/EBPalpha-dependent regulation of E2F complexes in a well-characterized cell line, 3T3-L1, and in stable transformants that conditionally express C/EBPalpha. C/EBPalpha and C/EBPbeta proteins are induced in 3T3-L1 preadipocytes during differentiation with different kinetics and potentially may regulate E2F/Rb family complexes. In pre-differentiated cells, three E2F complexes are observed: cdk2/E2F/p107, E2F/p130 and E2F4. cdk2/E2F/p107 complexes are induced in nuclear extracts of 3T3-L1 cells during mitotic expansion, but are not detectable in nuclear extracts at later stages of 3T3-L1 differentiation. The reduction in E2F/p107 complexes is associated with elevation of C/EBPalpha, but is independent of C/EBPbeta expression. Bacterially expressed, purified His-C/EBPalpha is able to disrupt E2F/p107 complexes that are observed at earlier stages of 3T3-L1 differentiation. C/EBPbeta, however, does not disrupt E2F/p107 complexes. A short C/EBPalpha peptide with homology to E2F is sufficient to bring about the disruption of E2F/p107 complexes from 3T3-L1 cells in vitro. Induction of C/EBPalpha in stable 3T3-L1 clones revealed that C/EBPalpha causes disruption of p107/E2F complexes in these cells. In contrast, E2F/p130 complexes are induced in cells expressing C/EBPalpha. Our data suggest that induction of p130/E2F complexes by C/EBPalpha occurs via up-regulation of p21, which, in turn, leads to association with and inhibition of, cdk2 kinase activity. The reduction in cdk2 kinase activity correlates with alterations of p130 phosphorylation and with induction of p130/E2F complexes in 3T3-L1 stable clones. Our data suggest two pathways of C/EBPalpha-dependent regulation of E2F/Rb family complexes: disruption of S phase-specific E2F/p107 complexes and induction of E2F/p130 complexes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10446255      PMCID: PMC148609          DOI: 10.1093/nar/27.17.3621

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  16 in total

1.  c-Myc is a critical target for c/EBPalpha in granulopoiesis.

Authors:  L M Johansen; A Iwama; T A Lodie; K Sasaki; D W Felsher; T R Golub; D G Tenen
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

2.  C/EBPalpha is a DNA damage-inducible p53-regulated mediator of the G1 checkpoint in keratinocytes.

Authors:  Kyungsil Yoon; Robert C Smart
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

3.  Cell cycle-dependent and cell cycle-independent control of transcription by the Drosophila E2F/RB pathway.

Authors:  Dessislava K Dimova; Olivier Stevaux; Maxim V Frolov; Nicholas J Dyson
Journal:  Genes Dev       Date:  2003-09-15       Impact factor: 11.361

4.  C/EBPalpha redirects androgen receptor signaling through a unique bimodal interaction.

Authors:  J Zhang; M Gonit; M D Salazar; A Shatnawi; L Shemshedini; R Trumbly; M Ratnam
Journal:  Oncogene       Date:  2009-11-09       Impact factor: 9.867

5.  Cyclin D3 maintains growth-inhibitory activity of C/EBPalpha by stabilizing C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes.

Authors:  Guo-Li Wang; Xiurong Shi; Elizabeth Salisbury; Yuxiang Sun; Jeffrey H Albrecht; Roy G Smith; Nikolai A Timchenko
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

6.  Expression and sub-cellular localization of the CCAAT/enhancer binding protein alpha in relation to postnatal development and malignancy of the prostate.

Authors:  Juan Zhang; John Erby Wilkinson; Mesfin Gonit; Rick Keck; Steven Selman; Manohar Ratnam
Journal:  Prostate       Date:  2008-08-01       Impact factor: 4.104

7.  Phosphorylation of C/EBPalpha inhibits granulopoiesis.

Authors:  Sarah E Ross; Hanna S Radomska; Bo Wu; Pu Zhang; Jonathon N Winnay; Laszlo Bajnok; Wendy S Wright; Fred Schaufele; Daniel G Tenen; Ormond A MacDougald
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

8.  Genetic ablation of CCAAT/enhancer binding protein alpha in epidermis reveals its role in suppression of epithelial tumorigenesis.

Authors:  Kari D Loomis; Songyun Zhu; Kyungsil Yoon; Peter F Johnson; Robert C Smart
Journal:  Cancer Res       Date:  2007-07-15       Impact factor: 12.701

9.  C/EBPalpha expression is partially regulated by C/EBPbeta in response to DNA damage and C/EBPalpha-deficient fibroblasts display an impaired G1 checkpoint.

Authors:  R Ranjan; E A Thompson; K Yoon; R C Smart
Journal:  Oncogene       Date:  2009-07-06       Impact factor: 9.867

10.  Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor alpha in adipocyte metabolism.

Authors:  Sarah E Ross; Robin L Erickson; Isabelle Gerin; Paul M DeRose; Laszlo Bajnok; Kenneth A Longo; David E Misek; Rork Kuick; Samir M Hanash; Kevin B Atkins; Sissel M Andresen; Hilde I Nebb; Lise Madsen; Karsten Kristiansen; Ormond A MacDougald
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.